BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 6170267)

  • 1. [Effect of azathioprine and inosiplex on rosette formation by lymphocytes from normal donors and from patients with neoplasia (author's transl)].
    De Simone C; Capozzi C; Campo S; Ricca D; Matteucci G
    Ann Sclavo; 1981; 23(1):116-24. PubMed ID: 6170267
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inosiplex, a stimulating agent for normal human T cells and human leukocytes.
    Wybran J; Govaerts A; Appelboom T
    J Immunol; 1978 Sep; 121(3):1184-7. PubMed ID: 80429
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effects of azathioprine and levamisole on rosette-forming cells of healthy subjects and cancer patients.
    Verhaegen H; De Cock W; De Cree J
    Clin Exp Immunol; 1977 Aug; 29(2):311-5. PubMed ID: 908176
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of methisoprinol on E-rosette formation by trypsin-treated lymphocytes.
    Gomez G; Lucivero G; Antonaci S
    Boll Ist Sieroter Milan; 1981; 60(4):302-6. PubMed ID: 6173046
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro effect of inosiplex on T lymphocytes. I. Influence on T cells with receptors for IgG (T gamma).
    De Simone C; Meli D; Sbricoli M; Rebuzzi E; Koverech A
    J Immunopharmacol; 1982; 4(1-2):139-52. PubMed ID: 6185596
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Immunostimulative therapy of herpes zoster (three years' experience with inosiplex) (author's transl)].
    Bunta S; Peris Z
    Z Hautkr; 1981 Nov; 56(22):1457-66. PubMed ID: 6171939
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An open-label trial of immunomodulation therapy with inosiplex (Isoprinosine) in patients with alopecia totalis and cell-mediated immunodeficiency.
    Galbraith GM; Thiers BH; Fudenberg HH
    J Am Acad Dermatol; 1984 Aug; 11(2 Pt 1):224-30. PubMed ID: 6207216
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inosiplex: an immunomodulation model for the treatment of viral disease.
    Ginsberg T; Glasky AJ
    Ann N Y Acad Sci; 1977 Mar; 284():128-38. PubMed ID: 81634
    [No Abstract]   [Full Text] [Related]  

  • 9. In vitro studies on cell-mediated immunity in patients treated with inosiplex for herpes virus infection.
    Bradshaw LJ; Sumner HL
    Ann N Y Acad Sci; 1977 Mar; 284():190-6. PubMed ID: 81637
    [No Abstract]   [Full Text] [Related]  

  • 10. Inosiplex for localized herpes zoster in childhood cancer patients: preliminary controlled study.
    Feldman S; Hayes FA; Chaudhary S; Ossi M
    Antimicrob Agents Chemother; 1978 Sep; 14(3):495-7. PubMed ID: 81655
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mechanism of host defense suppression induced by viral infection: mode of action of inosiplex as an antiviral agent.
    Ohnishi H; Kosuzume H; Inaba H; Okura M; Morita Y; Mochizuki H; Suzuki Y
    Infect Immun; 1982 Oct; 38(1):243-50. PubMed ID: 6183209
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Effects of inosiplex on host defense against infections (author's transl)].
    Ohnishi H; Kosuzume H; Inaba H; Shimada S; Tajima H; Suzuki Y
    Kansenshogaku Zasshi; 1981 Jul; 55(7):479-89. PubMed ID: 6173449
    [No Abstract]   [Full Text] [Related]  

  • 13. Methisoprinol effect on enriched B and T lymphocyte populations stimulated with phytohemagglutinin.
    Pasino M; Bellone M; Cornaglia P; Tonini GP; Massimo L
    J Immunopharmacol; 1982; 4(1-2):101-8. PubMed ID: 6185593
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The immunomodulatory action of inosiplex in relation to its effects in experimental viral infections.
    Ohnishi H; Kosuzume H; Inaba H; Ohkura M; Shimada S; Suzuki Y
    Int J Immunopharmacol; 1983; 5(3):181-96. PubMed ID: 6194125
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Potentiation of cytotoxic effects of 5-fluorouracil by inosiplex on cancer cells].
    Miyoshi T; Ogawa S; Nobuhara M; Namba M
    Gan To Kagaku Ryoho; 1984 Mar; 11(3):440-4. PubMed ID: 6200078
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inosiplex treatment of acquired immunodeficiencies: a clinical model for effective immunomodulation.
    Glasky AJ; Gordon J
    Methods Find Exp Clin Pharmacol; 1986 Jan; 8(1):35-40. PubMed ID: 2422507
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of inosiplex on the humoral and cell-mediated immune responses to intradermal human diploid cell rabies vaccine.
    Sriwanthana B; Phanuphak P; Thaweepathomwat M; Warrell MJ; Warrell DA; Suntharasamai P; Baer GM
    Southeast Asian J Trop Med Public Health; 1986 Dec; 17(4):543-9. PubMed ID: 2437660
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Therapy of rheumatic diseases with inosiplex].
    Becker H; Loers E; Helmke K; Federlin K
    Immun Infekt; 1986 May; 14(3):93-9. PubMed ID: 2423433
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Lymphocytes subpopulation in cancer's patients. Relationship with primitive anatomical location, histological type and clinical stage (author's transl)].
    Saiz Garcia F; Rodriguez Valverde V
    Bull Cancer; 1981; 68(1):32-9. PubMed ID: 6971668
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Methisoprinol effect on enriched B and T lymphocyte populations stimulated with phytohemagglutinin.
    Pasino M; Bellone M; Cornaglia Ferraris P; Tonini GP; Massimo L
    Boll Ist Sieroter Milan; 1981; 60(4):297-301. PubMed ID: 6173045
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.